Hubei Langxin Biochemical Pharmaceutical Co., Ltd. is a high-tech enterprise engaged in the research, development, production, and sales of chemical drug preparations and active pharmaceutical ingredients, focusing on innovative drug development in the fields of cardiovascular diseases, Alzheimer's disease, weight loss, and gastrointestinal disorders.

The project has a total investment of 150 million yuan, covering a total area of 36,000 square meters. The engineering plan includes two general API workshops compliant with national GMP standards, one sartan-class API workshop, one comprehensive preparation workshop, as well as auxiliary facilities such as offices, warehouses, water supply, power supply, and sewage treatment systems. Upon operation, the project will produce 50 tons of APIs and pharmaceutical intermediates annually for treating cardiovascular and gastrointestinal diseases, with an estimated annual output value of approximately 300 million yuan.

Langxin's robust management system and R&D team not only provide you with high-quality products but also offer professional solutions. We will continuously enhance our corporate sense of responsibility and look forward to working with you to create a healthy and fulfilling life for patients.